CG Oncology touts interim Phase 3 bladder cancer data as it gears up to compete with ImmunityBionews2024-05-03T15:23:35+00:00May 3rd, 2024|Endpoints News|
Ro CEO Zachariah Reitano talks GLP-1 drug pricing, shortages and compounded shotsnews2024-05-03T15:11:53+00:00May 3rd, 2024|Endpoints News|
Royalty Pharma’s milestone payment to Arrowhead; Abeona’s $75M offeringnews2024-05-03T14:31:54+00:00May 3rd, 2024|Endpoints News|
AEON fails another migraine trial, shares halve as company reviews optionsnews2024-05-03T13:52:27+00:00May 3rd, 2024|Endpoints News|
Bipartisan draft bill would pay hospitals more to combat drug shortagesnews2024-05-03T11:12:20+00:00May 3rd, 2024|Endpoints News|
Lonnel Coats announces retirement from Lexicon; Another shakeup in Vir’s C-suitenews2024-05-03T11:00:31+00:00May 3rd, 2024|Endpoints News|
Amgen touts new data for drug MariTide, moving rapidly into Phase 3 worknews2024-05-02T21:34:16+00:00May 2nd, 2024|Endpoints News|
Pharma companies soften tone on full IRA impactnews2024-05-02T20:24:16+00:00May 2nd, 2024|Endpoints News|
AstraZeneca’s Calquence hits endpoint in first-line mantle cell lymphoma trialnews2024-05-02T19:25:55+00:00May 2nd, 2024|Endpoints News|
ICER pushes back on FDA’s potential conversion of Sarepta’s gene therapy to full approvalnews2024-05-02T18:28:50+00:00May 2nd, 2024|Endpoints News|